Canyam
AI summaries for academic research
Home
Literature Help
Subscribe
Favorites
Tools
Analysis
Summary
Patents
Not logged in
Back
Journal Details
Molecular Pharmaceutics
IF
4.5
Papers
1029
Citations
23617
Related Insights
0
subscribe
Journal Papers
884
Related Insights
0
Journal Papers
884
Publication Date
Publication Date
IF
Citations
PET Imaging of Phosphorylated RIPK1 Reveals Necroptosis Activation In Vivo
Molecular Pharmaceutics
IF
4.5
2026-08-03
0
PRE
AI
Sun Mi Park; Tae Sup Lee; Jieun Lee; Jiwon Yoon; Bom Sahn Kim; Byung Seok Moon
Share
Save
Fibroblast-Selective Lipid Nanoparticles for Tumor Stromal Transfection
Molecular Pharmaceutics
IF
4.5
2026-08-03
0
PRE
AI
Na Yeon Kim; Yeon Hui Yang; Takatsugu Ishimoto; Ji-Ho Park
Share
Save
Predicting First-in-Human Pharmacokinetics: Comparative Evaluation of Standard PBPK; High-Throughput PBPK; and Machine Learning
Molecular Pharmaceutics
IF
4.5
2026-08-03
0
OA
AI
Silvan Käser; Davide Bassani; Neil John Parrott; Kenichi Umehara; Marie-Laure Delporte; Pascale David-Pierson
Share
Save
Fluorescence-Guided Surgery of Rhabdomyosarcoma Using a B7-H3 Targeted Antibody–Fluorophore Conjugate
Molecular Pharmaceutics
IF
4.5
2026-06-11
0
PRE
AI
Ritika Gupta; Evie G. Ehrhorn; Ashruti Pant; Samuel S. Streeter; Kimberley S. Samkoe; Eric R. Henderson; Aaron M. Mohs
Share
Save
Correction to “Pharmacokinetics; Biodistribution; Immunogenicity; and Model-Informed-Based PK/PD Model of a Next-Generation Advanced Novel Gene Therapy for Hemophilia”
Molecular Pharmaceutics
IF
4.5
2026-06-08
0
OA
AI
Dehu Dou; Jing Lu; Peixin Sangchen; Chaorui Guo; Deli Li; Fengxia He; Xi Zhu; Xuefeng Zhang; Xijing Chen
Share
Save
Visualizing the Spatiotemporal Redistribution of Drugs in Destabilizing Nanoemulsions: A Quantitative Solution 1H NMR Approach
Molecular Pharmaceutics
IF
4.5
2026-06-08
0
PRE
AI
Keisuke Ueda; Saeko Tomita; Yushi Sunazuka; Kenjirou Higashi; Kunikazu Moribe
Share
Save
Fluorinated Chitosan-Based Theranostic Nanocarrier System for Image-Guided Synergistic Treatment of Hepatocellular Carcinoma
Molecular Pharmaceutics
IF
4.5
2026-06-07
0
PRE
AI
Xiaoliang Zhao; Yuxin Wang; Na Hou; Danying Shang; Cunjin Wang; Weijie Zhang; Jing Zhang
Share
Save
PET Imaging Characterization of Sphingosine-1-Phosphate Receptor 2 in a Mouse Model of Esophageal Adenocarcinoma and Metastatic Lymph Node
Molecular Pharmaceutics
IF
4.5
2026-06-06
0
PRE
AI
Hong Chen; Lin Qiu; Wenjuan Zhou; Hao Jiang; Shuxian Xu; Sandip B. Jadhav; Anil Kumar Soda; Guangyong Peng; Zibo Li; Robert J. Gropler; Zhude Tu
Share
Save
Enhanced Therapeutic Efficacy of Combined Photothermal Therapy and Doxorubicin Chemotherapy in Anaplastic Thyroid Carcinoma: An Innovative Treatment Approach
Molecular Pharmaceutics
IF
4.5
2026-06-04
0
PRE
AI
Fan Yang; Yili Zhou; Yi Xu; Hongzhong Zhou; Jinmiao Qu; Hongwei Sun; Shixu Lv
Share
Save
Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06: An Albumin-Binding Fibroblast Activation Protein Inhibitor for Theranostics
Molecular Pharmaceutics
IF
4.5
2026-06-04
0
PRE
AI
Xiaoxue Tian; Liqin Wang; Chen He; Yuzhao Teng; Yuxi Zhang; Zhencun Cui; Jiangyan Liu
Share
Save
Pharmacokinetics and Dosimetry of 177Lu-DOTATATE in Patients with Advanced Well-Differentiated; Gastroenteropancreatic Neuroendocrine Tumors: Results from a Substudy of the Phase 3 XT-XTR008-3-01 Trial
Molecular Pharmaceutics
IF
4.5
2026-06-04
0
PRE
AI
Guangyu Ma; Yanliang Dong; Shuwei Sun; Yuan Wang; Huijuan Ji; Xiaodan Xu; Qiaoying Yang; Yabing Sun; Hui Zhou; Xiaojun Zhang; Ting Ye; Ang Yin; Ruimin Wang
Share
Save
Targeting NETosis in the Lung: Respiratory Delivery of Neutrophil-Specific NEBP-Liposomes for Enhanced Therapy of Acute Lung Injury
Molecular Pharmaceutics
IF
4.5
2026-06-04
0
PRE
AI
Xin Liu; Yun Liu; Wuqi Guo; Xinghua Li; Yiran Han; Qiang Huo; Yang Liu; Yimin Niu
Share
Save
A Universal Tag To Supercharge Proteins for Cytosolic Delivery
Molecular Pharmaceutics
IF
4.5
2026-06-02
0
PRE
AI
Yanan Quan; Weina Jing; Lei Peng; Wanrong Yang; Wanyi Tai
Share
Save
Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15N Solid-State NMR: Derisking the Drug’s Chemical Liability
Molecular Pharmaceutics
IF
4.5
2026-06-02
0
PRE
AI
Ales Medek; Mark Strohmeier; Andrew Schuchart; Courtney K. Maguire; Lori Ferris
Share
Save
Correction to “Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy”
Molecular Pharmaceutics
IF
4.5
2026-06-01
0
OA
AI
Fangzhou Yang; Yunqian Lu; Xiaoxue Lang; Lina Sun; Hang Zou; Ziting Zhou; Yaoyao Guo; Yifei Guo; Xiangtao Wang; Meihua Han
Share
Save
Effect of Amorphization on the Punch Sticking Propensity of Organic Powders
Molecular Pharmaceutics
IF
4.5
2026-05-31
0
PRE
AI
Vikram Chandrashekhar Joshi; Changquan Calvin Sun
Share
Save
A Multitechnique Spectroscopy Platform for Monitoring Heterogeneities in the Higher-Order Structure of mAb Therapeutics
Molecular Pharmaceutics
IF
4.5
2026-05-30
0
PRE
AI
Divya Agrawal; Srishti Joshi; Saxena Nikita; Sonam Sriwastaw; Anurag S. Rathore
Share
Save
Laminin Gamma 2 (LAMC2)-Targeting F(ab′)2 for 89Zr Immuno-PET Imaging of Human NSCLC Xenograft Models
Molecular Pharmaceutics
IF
4.5
2026-05-29
0
PRE
AI
RenCai Lu; JianFang Zhang; GuangFa Bao; YanYan Kong; DongDong Xv; ShaoBo Wang
Share
Save
Voices in Molecular Pharmaceutics: Meet Dr. Hannes Steinkellner; Who Is Turning Engineered Proteins into Intracellular Therapies Using Cell-Penetrating Peptides
Molecular Pharmaceutics
IF
4.5
2026-05-28
0
OA
AI
Hannes Steinkellner
Share
Save
Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer
Molecular Pharmaceutics
IF
4.5
2026-05-27
0
OA
AI
Nghia Trong Nguyen; Tim Rheinfrank; Stefan Stangl; Falco Reissig; Susanne Kossatz; Johannes Notni
Share
Save